Enjoy your Meals while Limiting the Absorption of Fats and Sugars

Caleetech is a biotechnology start-up company specializing in providing novel solutions for obesity and diabetes by limiting absorption of fats and sugars.

The Need

Obesity is not only a cosmetic issue, it is a challenging medical condition that increases the likelihood of chronic conditions such as diabetes and heart disease. For instance, the prevalence of obesity among adults in the US exceeds 42% in recent years, incurring USD 147 billion per year in healthcare cost,^[1] alongside billions of dollars spent annually on diets and weight loss treatments. Even with all available solutions on the market, many people are still struggling with this challenge. Moreover, existing solutions are, restrictive (thus limited), or invasive.

Even in the non-obese market, looking for a healthy diet, the demand for nonrestrictive solutions is on a constant rise.

Most of the existing preventive solutions don’t give consumers control over the level of their caloric intake.

• [1] CDC: Adult Obesity facts. https://www.cdc.gov/obesity/data/adult.html

Caleetech’s Solution:

Caleetech provides a groundbreaking and unique solution allowing to reduce caloric absorption with a transient, non-invasive and affordable product.  The product creates an intestinal overlay on the gastrointestinal tract (GIT).  This layer acts as a temporary passive barrier, limiting, by a significant amount, the absorption of fats and sugars into the bloodstream.

• A high safety profile that - does not affect food taste or one’s appetite
• Providing control over caloric intake.
• Allows weight and sugar management, contributing to the quality of life
• Reducing the need for invasive bariatric surgeries
• The company plans to conduct during 2022, a clinical study in Rambam Medical center to prove the safety and efficacy of the product in healthy adults

Market Potential

• No similar solutions are currently in clinical use.
• Corresponds with very large market size of dietary supplements and bariatric surgeries
• The global weight loss market is projected to grow by $245.41 billion in 2022 at a CAGR of 6.9%%.
• Potential for tailored and personalized use in the future.